Carna Biosciences Inc. of Kobe, Japan, a provider of intercellular drug discovery programs and services, has signed an agreement with Caliper Life Sciences Inc. of Hopkinton, Mass. The collaboration will provide the latter with protein kinases and ProfilerPro Kinase Selectivity Assay Kits. Combining advanced devices with reagents will influence therapy for cancer and neurological and autoimmune diseases.